Jia Jianping, M.D, Ph.D
Neurologist and Professor
Director of Center for Neurological disorders, Beijing Friendship Hospital, Beijing, China
Director of Department of Neurology, Beijing Friendship Hospital, Beijing, China
Chairman of Chinese Dementia and Cognitive Impairment Society
President of Chinese Corgnitive Impairment Disorders Association
Director of Alzheimer’s Disease Center, Beijing Institute for Brain Disorders

Prof. Jia got M.D. and Ph.D. degree of Neurology from Bethune Medical University in 1990, and got Commonwealth Practitioner's license and Associate professor title in University of Sydney Medical School, Australia and University of Otago Medical School, New Zealand from 1990 to 1999.Prof. Jia was appointed to Director of Department of Neurology of Xuanwu Hospital, Capital Medical University from 1999 to 2015 and Director of Center of Alzheimer’s Disease, Beijing Institute for Brain Disorders from 2013 to date. Prof. Jia was appointed to Director of Center for Neurological disorders and Director of Department of Neurology, Beijing Friendship Hospital from 2015 to date.

Prof. Jia is the former chairman of Committee of Neurology branch of the Chinese Medical Association, former chairman of Neurology branch of the Chinese Medical Doctor Association, chairman of Dementia and Cognitive disorders of Neurology branch of the Chinese Medical Doctor Association, vice president of Beijing Society for Neuroscience, editorial board member, associate editor and editor of 25 kinds of academic journals.

Research of Prof. Jia and his team was mainly on basic and clinical studies of dementia, including:
1)    Established the largest sample bank of dementia in China, in order to facilitate the exploration in pathogenesis of cognition-related disorders;
2)    Carried out multi-center study of dementia and mild cognitive impairment(MCI) in China so as to figure out the status of dementia in China;
3)    Established the first registered network of the familial AD (FAD) in China, intending to explore the pathological mechanisms of AD;
4)    Established a novel AD animal model,PSEN1V97L mutation mice, basing on the previous findings of the team in Chinese FAD study, which provides new methods and tools in exploring the pathological mechanisms of AD;
5)    Found the crucial functions of AD-related pathogenic/susceptible genes and key proteins in Chinese populations, providing new evidence for the genetics studies of AD;
6)    Found new biomarkers and technology in early diagnosis and screening of AD, so as to effectively intervene and treat AD in the early stage.

Prof. Jia has undertaken and held more than 60 program or projects, including National Twelve-Five Science and Technology Projects, National 11th "Five-Year" Technology Support Programs, the 10th Five Years Key Programs, “863” Program, “973” Program and Natural Science Foundation of China etc., he has published over 140 SCI papers, the highest Impact Factor (IF) of paper is 16.44, and more than 700 Chinese core periodical. In 2013, Prof. Jia as the first person of “Investigate of the epidemiology, etiology and diagnosis and treatment of dementia and mild cognitive impairment” was awarded for Second Award of National Scientific and Technological Progress Award, Second Award of Beijing Scientific and Technological Progress Award and more than 7 other awards. What’s more, Prof. Jia has published 45 textbooks and treatise.

Publications:
[1]    Xing Y, Tang Y, Zhao L, Wang Q, Qin W, Zhang JL, Jia J. Plasma Ceramides and Neuropsychiatric Symptoms of Alzheimer's Disease. J Alzheimers Dis, 2016.
[2]    Wang W, Lu L, Wu QQ, Jia JP. Brain Amyloid-beta Plays an Initiating Role in the Pathophysiological Process of the PS1V97L-Tg Mouse Model of Alzheimer's Disease. J Alzheimers Dis, 2016.
[3]    Zhang Z, Song M, Liu X, Su Kang S, Duong DM, Seyfried NT, Cao X, Cheng L, Sun YE, Ping Yu S, Jia J, Levey AI, Ye K. Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer's disease. Nat Commun, 2015, 6:8762.
[4]    Wang XL, Li CJ, Xing Y, Yang YH, Jia JP. Hypervalinemia and hyperleucine-isoleucinemia caused by mutations in the branched-chain-amino-acid aminotransferase gene. J Inherit Metab Dis, 2015.
[5]    Wang Q, Jia J, Qin W, Wu L, Li D, Wang Q, Li H. A Novel AbetaPP M722K Mutation Affects Amyloid-beta Secretion and Tau Phosphorylation and May Cause Early-Onset Familial Alzheimer's Disease in Chinese Individuals. J Alzheimers Dis, 2015, 47(1):157-65.